China grants conditional approval for Merck’s COVID treatment
Molnupiravir, developed by Merck, is approved to be used in adult patients who have mild-to-medium COVID infection and a high risk…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVID treatment
Health minister reviews status of essential medicines and drugs with pharma companies in view of…
Pharma companies asked to keep a close watch on global supply chain scenario to ensure adequate stocks and availability of all…
Drugmakers and scientists begin hunt for long COVID treatments
Researchers, biotech companies and public health experts say major pharma companies are integral to getting a proven treatment for…
US FDA authorises first oral antiviral to treat COVID
The antiviral, Paxlovid, is not authorised for the pre-exposure or post-exposure prevention of COVID-19 or for initiation of…
Merck announces two million euros as support to India for Covid relief
The aid is being utilised for procuring equipment of 250 oxygen concentrators, 100 ventilator units, and setting up oxygen…
Roche gets EUA in India for antibody cocktail (Casirivimab and Imdevimab) to treat COVID-19
Partners with Cipla for pan-India distribution
Eli Lilly accelerates baricitinib’s availability in India
Lilly is working with the Indian government to provide baricitinib donations in conjunction with the permission